Free Trial

Aura Biosciences (AURA) Insider Trading & Ownership

Aura Biosciences logo
$8.75 -0.17 (-1.91%)
(As of 11/20/2024 ET)

Aura Biosciences (NASDAQ:AURA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$1.06 M
Get AURA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aura Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AURA Insider Buying and Selling by Quarter

Aura Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/18/2024Janet Jill HopkinsInsiderSell11,822$9.36$110,653.92  
10/29/2024Amy ElazzouziVPSell553$10.74$5,939.22  
10/29/2024Los Pinos Elisabet DeInsiderSell9,200$10.74$98,808.00  
10/18/2024Julie B FederCFOSell25,131$12.03$302,325.93  
10/18/2024Los Pinos Elisabet DeInsiderSell24,992$12.04$300,903.68  
10/16/2024Mark PlavsicCTOSell7,383$9.85$72,722.55  
1/23/2024Julie B FederCFOSell6,609$7.64$50,492.76  
1/23/2024Los Pinos Elisabet DeInsiderSell15,853$7.64$121,116.92  
(Data available from 1/1/2013 forward)

AURA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Aura Biosciences includes Amy Elazzouzi, Cadmus Rich, David Michael Johnson, Janet Jill Hopkins, Julie B Feder, Los Pinos Elisabet De, Mark Plavsic, Matrix Capital Management Comp, and Rosch Mark De. Learn more on insiders at AURA.

5.40% of Aura Biosciences stock is owned by insiders. Learn more on AURA's insider holdings.

The following insiders have purchased AURA shares in the last 24 months: David Michael Johnson ($823,225.00), and Matrix Capital Management Comp ($29,040,000.00).

Insiders have purchased a total of 2,913,896 AURA shares in the last 24 months for a total of $29,863,225.00 bought.

The following insiders have sold AURA shares in the last 24 months: Amy Elazzouzi ($5,939.22), Janet Jill Hopkins ($110,653.92), Julie B Feder ($422,977.39), Los Pinos Elisabet De ($675,912.45), and Mark Plavsic ($72,722.55).

Insiders have sold a total of 125,863 Aura Biosciences shares in the last 24 months for a total of $1,288,205.53 sold.

Aura Biosciences Key Executives

  • Dr. Elisabet de los Pinos Ph.D. (Age 51)
    Founder, CEO, President & Director
    Compensation: $795.3k
  • Ms. Julie B. Feder (Age 54)
    CFO, Secretary & Treasurer
    Compensation: $505.45k
    1 recent trades
  • Mr. Patrick Nealon
    Senior Vice President of Clinical Development Operations
  • Dr. Bruce Brown M.D.
    Senior VP & Therapeutic Area Head of Urologic Oncology
  • Dr. Anthony Daniels M.D.
    Therapeutic Area Head of Ocular Oncology
  • Dr. Richard Mountfield Ph.D.
    Senior Vice President of Regulatory Affairs & Quality


This page (NASDAQ:AURA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners